New Portfolio - New Portfolio

Saleem

New Portfolio
Individual Investor
Ranked #475,702 out of 757,492 TipRanks' Investors
Success Rate
29%
147 out of 509
profitable transactions
Average Return
-13.33%
Average return
per transaction
Share this portfolio:

Portfolio Gain

1-Month Return▲ 7.84%
6-Month Return▲ 20.17%
12-Month Return▲ 64.89%
YTD Return▲ 33.22%
Total Return▼ 98.89%

Best Trade

Opened at
Closed at-
Gain▲ 1356.90%

Bio

52 week-lows only

Performance

25.76%0-25.76%
▲ 14.08%
▲ 5.22%
▲ 8.30%
Feb 2024
▲ 5.05%
▲ 3.27%
▲ 8.62%
Mar 2024
▼ 12.40%
▼ 4.03%
▼ 3.08%
Apr 2024
▲ 11.46%
▲ 5.06%
▲ 7.04%
May 2024
▼ 2.25%
▲ 3.53%
▼ 4.66%
Jun 2024
▲ 25.76%
▲ 1.21%
▲ 4.54%
Jul 2024
▼ 4.21%
▲ 2.34%
▲ 5.58%
Aug 2024
▲ 2.65%
▼ 0.40%
▲ 6.97%
Sep 2024
TipRanks AverageS&P 500Investor Portfolio
▲ 14.08%▲ 5.22%▲ 8.30%
▲ 5.05%▲ 3.27%▲ 8.62%
▼ 12.40%▼ 4.03%▼ 3.08%
▲ 11.46%▲ 5.06%▲ 7.04%
▼ 2.25%▲ 3.53%▼ 4.66%
▲ 25.76%▲ 1.21%▲ 4.54%
▼ 4.21%▲ 2.34%▲ 5.58%
▲ 2.65%▼ 0.40%▲ 6.97%

Recent Activity

Company Name
% of Portfolio
Return
No. of Transactions
Last Transaction
Date
Asensus Surgical
▼ 63.85%
2
Close
Aug 22, 2024
Acorda Therapeutics
▼ 99.99%
2
Close
Aug 22, 2024
Macatawa Bank
▲ 90.44%
2
Close
Aug 02, 2024
Wintrust Financial
0%
▲ 10.03%
1
Open
Aug 02, 2024
Equitrans Midstream
▲ 125.12%
2
Close
Jul 22, 2024
CloudMD Software & Services
▼ 98.59%
2
Close
Jul 11, 2024
FNCB Bancorp
▲ 29.34%
2
Close
Jul 02, 2024
Peoples Financial Services
0%
▲ 13.68%
1
Open
Jul 02, 2024
NeuBase Therapeutics
▼ 99.74%
2
Close
May 10, 2024
QSAM Biosciences
▼ 64.83%
2
Close
May 02, 2024
Societal CDMO
▼ 61.40%
2
Close
Apr 09, 2024
Calithera Bio
▼ 99.95%
2
Close
Apr 05, 2024
Bellicum Pharmaceuticals
▼ 97.89%
2
Close
Apr 03, 2024
Community West Bancshares
▲ 89.52%
2
Close
Mar 28, 2024
Callon
▲ 167.87%
2
Close
Mar 28, 2024
APA
0%
▼ 25.08%
1
Open
Mar 28, 2024
Community West Bancshares
0%
▲ 6.05%
1
Open
Mar 28, 2024
CymaBay Therapeutics
▲ 465.85%
2
Close
Mar 25, 2024
Orchard Therapeutics
▼ 74.31%
2
Close
Jan 24, 2024
Green Plains Partners
▲ 72.99%
2
Close
Jan 08, 2024